![]() |
市場調查報告書
商品編碼
1744611
2032 年細胞農業市場預測:按產品類型、來源、分銷管道、技術、應用和地區進行的全球分析Cellular Agriculture Market Forecasts to 2032 - Global Analysis By Product Type (Tofu, Tempeh, Seitan, Quorn, and Other Product Types), Type, Source, Distribution Channel, Technology, Application and By Geography |
根據 Stratistics MRC 的數據,全球細胞農業市場預計在 2025 年達到 2,461.4 億美元,到 2032 年將達到 7,887.5 億美元,預測期內的複合年成長率為 18.1%。
細胞農業是生物技術的一個分支,專注於直接從細胞中生產農產品,而不是飼養動物或培育植物。它涉及培養動物細胞或利用微生物來生產肉類、乳製品、蛋類、皮革和其他材料。細胞農業旨在繞過傳統農業,減少對環境的影響,提高糧食安全,並提供符合倫理道德的替代方案,同時保持與傳統畜牧業相似的口感、質地和營養價值。
根據糧農組織統計資料庫 (FAOSTAT) 的數據,小麥產量預計將從 2022 年的每公頃 3,704.4 公斤下降到 2023 年的每公頃 3,625 公斤,大麥和其他粗粒產量也將出現類似的下降趨勢。
對永續蛋白質的需求不斷增加
細胞農業市場對永續蛋白質的需求日益成長,這源自於對更有效率、更環保的食品生產系統的需求。人口成長和肉類消費的增加進一步加劇了資源緊張,從而加速了人們對實驗室培育替代品的興趣。注重健康的消費者更青睞更乾淨、不含抗生素的蛋白質,而對動物福利的倫理擔憂則推動了對零殘忍產品的需求。此外,大型食品公司的扶持政策和投資進一步提振了市場,將細胞蛋白定位為未來食品安全的永續解決方案。
來自植物來源品的競爭壓力
與實驗室培育肉類不同,植物來源替代品無需監管審查,開發週期更短,並受益於現有供應鏈,因此更容易獲得。此外,消費者對植物來源替代品的熟悉度和偏好,使其被認為更天然,這為細胞蛋白質的市場佔有率擴張帶來了障礙。由於細胞農業仍面臨高昂的生產成本,價格敏感度進一步青睞植物來源產品。這種競爭格局迫使細胞蛋白公司快速創新,同時克服成本和可擴展性障礙。
不斷成長的糧食安全需求
由於傳統畜牧業面臨環境限制和資源效率低下的困境,日益成長的糧食安全需求正推動細胞農業市場的成長。細胞農業提供了一種永續的替代方案,它只需極少的土地和水資源,同時避免了傳統畜牧業對生態系統的影響。此外,透過在受控環境中實現本地生產,細胞農業減少了對易受干擾的複雜供應鏈的依賴。這使得培養蛋白質成為一種策略解決方案,能夠在日益成長的需求和氣候不確定性面前,建構更具韌性和適應性的糧食體系。
漫長的開發週期
冗長的研發和監管障礙會推遲產品上市,增加成本並降低投資者信心。這些阻礙阻礙了市場擴張,使傳統農業得以保持主導地位。此外,漫長的開發週期也可能導致技術過時,因為新技術的進步可能超過現有技術。漫長的等待時間也會降低消費者信心和採用率,因為這會引發人們對擴充性和可負擔性的懷疑。
COVID-19的影響
新冠疫情暴露了傳統肉類供應鏈的脆弱性,包括屠宰場關閉和通用感染疾病的風險,這加速了人們對細胞農業的興趣。由於封鎖措施中斷了傳統生產,對實驗室培育蛋白質等韌性替代方案的需求增加。隨著相關人員尋求能夠抵禦疫情的肉類解決方案,以及消費者對永續食品選擇的認知不斷提高,投資激增。然而,研發延遲和資金籌措挑戰暫時減緩了進展。整體而言,這場危機凸顯了對去中心化、安全食品體系的需求,並將細胞農業定位為應對未來中斷的長期解決方案。
分離物部分預計將在預測期內佔據最大佔有率
預計分離物細分市場將在預測期內佔據最大市場佔有率。這歸因於高效生產實驗室人造肉類對純淨且可擴展的細胞株的需求。關鍵成長要素包括幹細胞技術的進步、為降低成本而大力推廣無血清培養基,以及對穩定、無污染投入的需求。食品安全監管要求也強調了特性明確的分離物在確保產品品質和商業性可行性方面的重要性。
預計預測期內組織工程領域將以最高的複合年成長率成長。
預計組織工程領域將在預測期內實現最高成長率,這得益於對結構化、逼真的肉類替代品(可模擬傳統肉類)的需求。關鍵促進因素包括3D生物列印、支架開發和細胞培養技術的進步,這些技術使肌肉和脂肪組織的可擴展生產成為可能。消費者對真實質地和口味的期望,以及永續性和倫理方面的考量,將進一步推動組織工程食品的創新。
預計亞太地區將在預測期內佔據最大的市場佔有率,這得益於肉類需求的不斷成長和耕地面積的有限,這推動了永續替代品的出現。新加坡、日本和中國的政府支持、研發投入以及新創企業的新興企業正在加速。日益增強的健康和環保意識,加上對食品安全的擔憂,正在推動肉類的普及。此外,監管部門的核准以及與傳統肉類生產商的合作,也進一步推動了該地區市場的擴張。
預計北美將在預測期內實現最高的複合年成長率。這得益於消費者對永續和符合道德標準的蛋白質的強勁需求,以及氣候意識的增強。科技公司和食品巨頭的大量投資、美國食品藥物管理局 (FDA)/美國農業部的監管支持以及蓬勃發展的新興企業生態系統正在刺激創新。此外,積極的政府措施和與研究機構的合作正在加速美國和加拿大的產品開發和商業化。
According to Stratistics MRC, the Global Cellular Agriculture Market is accounted for $246.14 billion in 2025 and is expected to reach $788.75 billion by 2032 growing at a CAGR of 18.1% during the forecast period. Cellular agriculture is a field of biotechnology that focuses on producing agricultural products directly from cells, rather than raising animals or growing plants. It involves cultivating animal cells or using microorganisms to create meat, dairy, eggs, leather, and other materials. By bypassing traditional farming, cellular agriculture aims to reduce environmental impact, improve food security, and offer ethical alternatives to conventional animal agriculture while maintaining similar taste, texture, and nutritional value.
According to FAOSTAT data, wheat yields decreased from 3,704.4 kg/ha in 2022 to 3,625 kg/ha in 2023, with similar declining trends observed in barley and other coarse grains.
Rising demand for sustainable protein
The rising demand for sustainable protein in the cellular agriculture market is fuelled by the need for more efficient and eco-friendly food production systems, as conventional animal farming struggles to meet global protein demands without excessive environmental harm. Increasing population growth and meat consumption further strain resources, accelerating interest in lab-grown alternatives. Health-conscious consumers prefer cleaner, antibiotic-free protein, while ethical concerns over animal welfare drive demand for cruelty-free options. Additionally, supportive policies and investments from major food companies further propel the market, positioning cell-based protein as a sustainable solution for future food security.
Competitive pressure from plant-based alternatives
Unlike lab-grown meat, plant-based alternatives require less regulatory scrutiny, have shorter development cycles, and benefit from existing supply chains, making them more accessible. Additionally, consumer familiarity and preference for plant-based options, perceived as more natural, create hurdles for cell-based proteins to gain market share. Price sensitivity further favours plant-based products, as cellular agriculture still faces high production costs. This competitive landscape forces cell-based protein companies to innovate rapidly while overcoming cost and scalability barriers.
Increasing food security needs
As conventional animal farming struggles with environmental constraints and resource inefficiencies, the increasing need for food security is accelerating growth in the cellular agriculture market. Cellular agriculture provides a sustainable alternative, requiring minimal land and water while avoiding the ecological impacts of traditional livestock production. Moreover, by enabling local production in controlled environments, cellular agriculture reduces dependence on complex supply chains vulnerable to disruptions. This positions cultured proteins as a strategic solution for building more resilient and adaptable food systems in the face of growing demand and climate uncertainties.
Long development timelines
Extended research and regulatory hurdles slow product launches, increasing costs and reducing investor confidence. This stagnation can hinder market expansion, allowing traditional agriculture to maintain dominance. Moreover, prolonged timelines risk technological obsolescence, as newer advancements may outpace current developments. Consumer trust and adoption rates also suffer, as long waits can lead to skepticism about scalability and affordability.
Covid-19 Impact
The COVID-19 pandemic accelerated interest in cellular agriculture by exposing vulnerabilities in traditional meat supply chains, including slaughterhouse closures and zoonotic disease risks. Lockdowns disrupted conventional production, boosting demand for resilient alternatives like lab-grown protein. Investment surged as stakeholders sought pandemic-proof food solutions, while consumer awareness of sustainable options grew. However, R&D delays and funding challenges temporarily slowed progress. Overall, the crisis highlighted the need for decentralized, secure food systems, positioning cellular agriculture as a long-term solution for future disruptions.
The isolates segment is expected to be the largest during the forecast period
The isolates segment is expected to account for the largest market share during the forecast period, driven by the need for pure, scalable cell lines to produce lab-grown meat efficiently. Key growth factors include advancements in stem cell technology, the push for serum-free media to reduce costs, and the demand for consistent, contamination-free inputs. Regulatory requirements for food safety also emphasize the importance of well-characterized isolates in ensuring product quality and commercial viability.
The tissue engineering segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the tissue engineering segment is predicted to witness the highest growth rate, due to the demand for structured, realistic meat alternatives that mimic conventional meat. Key factors include advancements in 3D bio-printing, scaffold development, and cell culture techniques, enabling scalable production of muscle and fat tissues. Consumer expectations for authentic texture and taste, alongside sustainability and ethical concerns, further accelerate innovation in tissue-engineered food products.
During the forecast period, the Asia Pacific region is expected to hold the largest market share due to rising meat demand, and limited agricultural land, pushing sustainable alternatives. Government support, R&D investments, and start-ups in Singapore, Japan, and China accelerate innovation. Growing health and environmental awareness, coupled with food security concerns, boost adoption. In addition, regulatory approvals and partnerships with traditional meat producers further propel market expansion in the region.
Over the forecast period, the North America region is anticipated to exhibit the highest CAGR, fuelled by strong consumer demand for sustainable, ethical protein, backed by rising climate consciousness. Heavy investments from tech and food giants, supportive FDA/USDA regulations, and a thriving start-ups ecosystem drive innovation. Additionally, proactive government initiatives and partnerships with research institutions are accelerating product development and commercialization across the U.S. and Canada.
Key players in the market
Some of the key players profiled in the Cellular Agriculture Market include Eat Just, Inc., Perfect Day, Inc., Aleph Farms, UPSIDE Foods, BlueNalu, Inc., Formo GmbH, Remilk, Mosa Meat, Finless Foods, Meatable, Air Protein, Avant Meats, SuperMeat, Wildtype, and Shiok Meats.
In May 2025, Eat Just, Inc., has launched its new protein powder, Just One, which is now available at Whole Foods Market locations across the United States. This product is distinct for being made with just one ingredient: mung beans, a legume known for its high protein content and sustainability.
In January 2025, Upside Foods is aiming to launch chicken shreds its second product in the US by year-end. Despite its legal battle against Florida's leaders and an uncertain political landscape around alternative proteins, Upside Foods is looking to move forward. While the Californian startup is cleared to sell its cultivated chicken fillet containing 99% chicken cells it stopped selling this at restaurants last year with the product is in relatively tight supply.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.